Chrysea Labs
Chrysea Acquires Rodon Biologics to Strengthen Capabilities in Synthetic Biology and Biopharmaceutical Products Development. 13 February 2024 Chrysea acquires operational capability, skills and kn...
Leveraging synthetic biology and data analytics to unlock the sustainable development of high-value bioactives with unparalleled purity and volume at scale. DUBLIN, IRELAND AND CANTANHEDE, PORTUGA...
Juvenescence joins Banco Português de Fomento and 200M Fund in co-investment in Chrysea Laboratories
Juvenescence joins the 200M Fund portfolio in the investment in Chrysea Labs (“Chrysea”), a synthetic biology company developing high-value and difficult to source natural products, using proprieta...